A modular patient-derived organoid-xenograft platform reveals molecular and clinical trajectories of prostate cancer progression
Romuald Parmentier, Robin Dolgos, Raphaëlle Servant, Jing Wang, Luca Roma, Renaud Mével, Daniela Bossi, Heike Pueschel, Zoi Diamantopoulou, Tatjana Vlajnic, Frank Stenner, Arnoud J. Templeton, Hans‐Helge Seifert, Nicola Aceto, Jean-Philippe Paul. Theurillat, , Clémentine Le Magnen
This study establishes a patient-derived organoid-xenograft platform that models prostate cancer progression, identifies biomarkers, and predicts treatment response.
bioRxiv · Jan 5, 2026 · PreprintCancer Biology